Mostrar el registro sencillo del ítem

dc.contributor.authorRodríguez Álvarez, Cristobalina 
dc.contributor.authorGonzález de León, Beatriz
dc.contributor.authorPino Sedeño, Tasmania del
dc.contributor.authorSerrano-Pérez, Pedro
dc.contributor.authorBejarano Quisoboni, Daniel
dc.contributor.authorTrujillo Martín, María M.
dc.date.accessioned2023-12-15T21:05:07Z
dc.date.available2023-12-15T21:05:07Z
dc.date.issued2022
dc.identifier.issn1471-244X
dc.identifier.urihttp://riull.ull.es/xmlui/handle/915/34811
dc.description.abstractBackground: Non‑adherence to medication is a major obstacle in the treatment of depressive disorders. We systematically reviewed the literature to evaluate the effectiveness of interventions aimed at improving adherence to medication among adults with depressive disorders with emphasis on initiation and implementation phase. Methods: We searched Medline, EMBASE, The Cochrane Central Register of Controlled Trials (CENTRAL), PsycINFO, Social Science Citation Index and Science Citation Index for randomized or non‑randomized controlled trials up to January 2022. Risk of bias was assessed using the criteria of the Cochrane Collaboration. Meta‑analyses, cumulative and meta‑regression analyses for adherence were conducted. Results: Forty‑six trials (n = 24,324) were included. Pooled estimate indicates an increase in the probability of adherence to antidepressants at 6 months with the different types of interventions (OR 1.33; 95% CI: 1.09 to 1.62). The improvement in adherence is obtained from 3 months (OR 1.62, 95% CI: 1.25 to 2.10) but it is attenuated at 12 months (OR 1.25, 95% CI: 1.02 to 1.53). Selected articles show methodological differences, mainly the diversity of both the severity of the depressive disorder and intervention procedures. In the samples of these studies, patients with depression and anxiety seem to benefit most from intervention (OR 2.77, 95% CI: 1.74 to 4.42) and collaborative care is the most effective intervention to improve adherence (OR 1.88, 95% CI: 1.40 to 2.54). Conclusions: Our findings indicate that interventions aimed at improving adherence to medication among adults with depressive disorders are effective up to six months. However, the evidence on the effectiveness of long‑term adherence is insufficient and supports the need for further research efforts. Trial registration: International Prospective Register for Systematic Reviews (PROSPERO) number: CRD42017065723.
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.relation.ispartofseriesBMC Psychiatry (2022) 22:487
dc.rightsLicencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES
dc.titleEffectiveness of interventions to improve medication adherence in adults with depressive disorders: a meta-analysis.
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s12888-022-04120-w
dc.subject.keywordMajor Depressive Disorder
dc.subject.keywordMeta‑analysis
dc.subject.keywordSystematic review
dc.subject.keywordTreatment Adherence


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)
Excepto si se señala otra cosa, la licencia del ítem se describe como Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)